|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004096,
umls-concept:C0007584,
umls-concept:C0038056,
umls-concept:C0298130,
umls-concept:C0458827,
umls-concept:C0595726,
umls-concept:C0701315,
umls-concept:C0753791,
umls-concept:C0871261,
umls-concept:C1280500,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-4-21
|
|
pubmed:abstractText |
Cysteinyl leukotrienes are capable of inducing chemotaxis of eosinophils in vitro and within the airways of animals and humans in vivo.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0954-7894
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
42-51
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10051701-Acetates,
pubmed-meshheading:10051701-Adult,
pubmed-meshheading:10051701-Allergens,
pubmed-meshheading:10051701-Anti-Asthmatic Agents,
pubmed-meshheading:10051701-Asthma,
pubmed-meshheading:10051701-Blood Proteins,
pubmed-meshheading:10051701-Bronchial Hyperreactivity,
pubmed-meshheading:10051701-Bronchial Provocation Tests,
pubmed-meshheading:10051701-Cell Count,
pubmed-meshheading:10051701-Cell Survival,
pubmed-meshheading:10051701-Cross-Over Studies,
pubmed-meshheading:10051701-Double-Blind Method,
pubmed-meshheading:10051701-Eosinophil Granule Proteins,
pubmed-meshheading:10051701-Forced Expiratory Volume,
pubmed-meshheading:10051701-Humans,
pubmed-meshheading:10051701-Hypersensitivity, Delayed,
pubmed-meshheading:10051701-Hypersensitivity, Immediate,
pubmed-meshheading:10051701-Leukotriene Antagonists,
pubmed-meshheading:10051701-Male,
pubmed-meshheading:10051701-Patient Compliance,
pubmed-meshheading:10051701-Quinolines,
pubmed-meshheading:10051701-Ribonucleases,
pubmed-meshheading:10051701-Sputum,
pubmed-meshheading:10051701-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
|
|
pubmed:affiliation |
Department of Pulmonology, Leiden University Medical Center, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
